Chairs: Dannis van Vuurden (NL), Ibrahim Jalloh (UK), Janneke van den Bergen (NL), Jasper van der Lugt (NL) & Martin McCabe (UK)
Note that the programme is subject to change and will be continuously updated.
All times below refer to Central European Time (CEST).
Saturday, July 8, 2023
10:00 - 10:45
M4.01 Epidemiology + 2021 WHO Classification
Martin McCabe, United Kingdom
11:00 - 11:45
M4.02 NF1 and other predisposition syndromes
Marjolijn Jongmans, Netherlands
12:00 - 12:45
M4.03 Neurosurgical aspects of the management of brain tumours in children
tbc
12:45 - 13:45
Lunch Break
13:45 - 14:30
M4.04 Radiotherapy - protons
tbc
14:45 - 15:30
M4.05 Low grade gliomas in children
Eric Bouffet, Canada
Sunday, July 9, 2023
10:00 - 10:45
M4.06 High grade gliomas in children
Darren Hargrave, United Kingdom
11:00 - 11:45
M4.07 Medulloblastoma subtypes + Other embryonal tumours
tbc
12:00 - 12:45
M4.08 Ependymoma
Timothy Ritzmann, United Kingdom
12:45 - 13:45
Lunch Break
13:45 - 14:30
M4.09 Delayed effects
Judith De Bont, Netherlands
14:45 - 15:30
M4.10 Future directions of clinical trials for paediatric neuro-oncology
Sabine Mueller, United States
15:30 - 16:30
Test
CME credits
The European Association of Neuro-Oncology (EANO) will be seeking accreditation from the European Accreditation Council of Continuing Medical Education.
